Table 2 E. coli expression strains used in this study.

From: Membrane directed expression in Escherichia coli of BBA57 and other virulence factors from the Lyme disease agent Borrelia burgdorferi

BL21(DE3)F ompT hsdSB (rB mB) gal dcm λDE3[PlacUV5- T7RNAP]Invitrogen #C6000-03
C43(DE3)BL21(DE3); uncharacterized mutations described in102Lucigen #60446-1
Lemo21(DE3)BL21(DE3); pLemo[pACYC184-PrhaBAD-lysY, chloramphenicolR]New England Biolabs #C2528H
KTD101Δtig100 Δ(araD-araB)567 ΔlacZ4787(::rrnB-3) lacIP-4000(lacIQ or lacI+108) rph-1 Δ(rhaD-rhaB)568, hsdR514104
KTD101(DE3)KTD101; λDE3[PlacUV5- T7RNAP]This work
BL21-AIF ompT hsdSB (rB mB) gal dcm araB::T7RNAP-tetA (tetracyclineR)Invitrogen #C6070-03